VIATRIS INC (VTRS)
NASDAQ • Healthcare
Last close at August 10, 2026 at 20:00 UTC
Fundamentals Charts
About VIATRIS INC
Viatris Inc. operates in healthcare as a maker of branded, generic, and specialty medicines, trading on NASDAQ under VTRS. Its portfolio spans treatments from Lyrica and Lipitor to biosimilars and raw pharmaceutical ingredients, and it generated $14.3 billion of revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
VIATRIS INC's Technical Indicators Summary
Viatris presents a neutral technical stance with clear short-term weakness offset by support from longer-term moving averages: price sits below recent 10–20 day averages but remains above the 100/200-day levels, producing mixed signals. Momentum indicators are conflicted—oscillators show oversold readings while CCI and momentum readings remain negative—while ADX indicates a lack of strong directional conviction and ATR implies modest volatility. Volume trends lean toward distribution, which tempers any short-lived oversold bounce potential. Technical takeaway: indicators are mixed and favor neither side decisively, leaving a neutral bias until trend and volume align.
| Indicator | Value |
|---|---|
RSI (14) | 40.33 |
Stochastic %K (14, 3, 3) | 6.79 |
CCI (20) | -146.09 |
WPR (14) | -93.36 |
Momentum (10) | -1.36 |
MFI | 42.91 |
MACD Level (12, 26) | 0.07 |
Bollinger Bands | $16.12 - $18.31 |
ATR (14) | $0.57 (3.53%) |
ADX (14) | 20.93 |
OBV | 230,140,386 |
Classic Pivot Point | $16.47 |
Fibonacci Pivot Point | $16.47 |
Simple Moving Averages | $14.15 - $17.30(5 indicators) |
Exponential Moving Averages | $14.16 - $17.04(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
VTRS finished the last trading session with a tiny decline, closing -0.91% beneath the prior close of 16.43. VTRS posts Q2 revenue up 4.9% to $3.76B and non-GAAP EPS of $0.69, topping estimates.
Trading Volume
Above 10d avg 11.7M
12.7M
vs S&P 500 Today
Underperforming Market
-0.85%
52-Week Position
Upper range
76.5%
Updated: August 11, 2026 at 12:39 UTC